From the publisher feed

CG Oncology's bladder cancer immunotherapy reduced risk of tumor recurrence by 68% — results that may change how physicians treat certain patients.

Read the original at STAT ↗

Opens the original publisher page. Access, copyright and subscriptions are controlled by the publisher.

A useful next step

  1. Read the short publisher description here.
  2. Open the full report directly at the publisher.
  3. Compare this topic with other sources when useful.